Bunge Global SA: December 2025 Stock Report

Company Overview

Bunge Global SA, headquartered in Chesterfield, Missouri, stands as a formidable entity in the agribusiness and food sector, prominently positioned within the farm products industry. Founded in 1818, the company operates through four primary segments: Agribusiness, which oversees the purchase, storage, transportation, processing, and sale of agricultural commodities (including oilseeds and grains); Refined and Specialty Oils, which provides both packaged and bulk oils and fats; Milling, which focuses on wheat flours and corn milling products; and Sugar and Bioenergy, which is engaged in the production of sugar and ethanol as well as electricity generation from sugarcane byproducts.

With a robust total revenue exceeding $60 billion, Bunge has cemented its reputation as a leader in the agricultural supply chain, demonstrating both financial resilience and growth potential in a vital sector known for stability. Analysts are optimistic about Bunge's trajectory, projecting a target high stock price of $120.00, which aligns with the strong performance of the farm products industry, warranting a recommendation to buy for potential investors.

52-Week Price Performance Analysis

52-Week Price Performance Chart

The 52-week price chart for Bunge Global SA (NYSE: BG) illustrates a notable performance, with the stock reflecting an increase of approximately 18.93% over the past year. Currently priced at $88.90, it has established significant trend lines that indicate a strong bullish sentiment.

• Key Price Levels:
• 52-Week High: $99.55
• 52-Week Low: $67.40
• Current Price: $88.90
• 50-Day Moving Average: $94.28

The stock's current position indicates it's trading below its 50-day moving average, hinting at a possible short-term bearish sentiment. However, the long-term trend remains bullish, as the stock has been supported by a rising trendline that connects higher lows, which signifies consistent buying interest.

Support and Resistance

• Key Support Level: Established at $75, the stock has shown resilience, rebounding from this range multiple times.
• Resistance Level: The stock has faced challenges around the $100 mark, which has acted as a ceiling, particularly during peaks observed in October and November.

The chart indicates that Bunge remains near its support level with recent price fluctuations signaling a potential adjustment phase. A decisive break below the support could lead to further downside risk, while a rally beyond resistance may unlock significant upside potential.

Financial Performance and Metrics

Delving into Bunge's financial metrics reveals a robust structure underpinning its operations.

• Total Revenue: Approximately $60.11 billion
• EBITDA: About $2.08 billion

These metrics reflect strong revenue generation capacity, which positions the company favorably for future growth and profitability. Moreover, the trading dynamics show: - Shares Outstanding: 193,361,047 - Shares Shorted: 5,326,450, representing approximately 0.0336% of the float, which suggests a generally positive sentiment among investors.

Analysts' price predictions further bolster Bunge's outlook, forecasting: - Target High Price: $120.00 - Mean Price Target: $108.44 - Median Price Target: $110.00

The wide span of price targets implies a potential for significant price appreciation, reinforcing the recommendation to consider a buy position in light of the favorable financial indicators.

Recent News and Developments

Bunge Global SA recently completed a strategic merger with Viterra Limited, forming a leading global agribusiness powerhouse. This merger is anticipated to enhance operational efficiencies and broaden Bunge's global network across diverse geographies and crop types.

Key announcements stemming from this merger include: - Updated EPS Guidance: Full-year 2025 adjusted earnings per share revised to between $7.30 and $7.60, reflective of the merger synergies. - Restructured Reporting: Segment reporting has been realigned to align with the newly formed operational value chain.

From an investment perspective, major financial maneuvers include: - A $1.3 billion senior notes offering aimed at supporting corporate objectives. - An expansion of the share repurchase program by an additional $500 million, signaling robust confidence in the company's future.

These strategic developments, coupled with favorable market conditions, underline Bunge's commitment to maintaining a solid financial footing while poised for significant growth.

Market Sentiment and Analyst Recommendations

Market sentiment surrounding Bunge Global SA is overwhelmingly positive, especially post-merger, as highlighted by various analyst upgrades.

• Barclays Rating: Upgraded to 'Overweight' with a price target increase to $120.
• Morgan Stanley Rating: Upgraded to 'Overweight', signaling confidence in growth prospects attributed to the merger's success.

Analyst recommendations convey a consensus "buy" signal, with a mean recommendation score of 1.56, which traditionally reflects a strong buy sentiment. The positive outlook is supported by a total of nine analyst opinions, contributing to a prevailing bullish stance among investors.

Conclusion

In conclusion, Bunge Global SA presents a compelling investment opportunity within the agribusiness sector, underscored by its strong financial performance, favorable analyst recommendations, and strategic developments post-merger with Viterra. With a total revenue exceeding $60 billion and an increasing share price, investors may find the current valuation attractive, particularly as it trades below its historical averages. However, market participants should remain cognizant of potential risks, including short-term price volatility and broader market fluctuations. The recommended entry point for prospective investors falls between the current price of $88.90 and the support level near $75, offering both a safeguard against downside while capturing potential upside towards the identified price target range.